Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy pens must be refrigerated between 2°C and 8°C, but a single pen can be kept at room temperature for a limited period if needed — the Wegovy Summary of Product Characteristics (SmPC), available via the electronic Medicines Compendium, gives the exact window and conditions. If your pen has been out of the fridge, whether or not it is still safe to use depends on how long it has been unrefrigerated, the temperature it reached, and whether it has been exposed to direct light or heat. These are prescription-only medicines requiring clinical oversight; always check the Patient Information Leaflet inside your pack and speak to your prescriber or pharmacist if you are uncertain.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It happens more often than you might think. You put the shopping away, the pen stays on the side, and you only notice the next morning. Before you either use it or throw it away, it helps to know what the official guidance actually covers.
The Wegovy SmPC sets out a specific maximum period and a maximum temperature for unrefrigerated storage. NHS guidance on semaglutide echoes this, directing patients to the leaflet for the precise figures because those details can be updated by the manufacturer and must be read from the current version of the pack rather than from any third-party source. The principle is consistent: the clock starts the moment the pen leaves the fridge, and the temperature ceiling matters as much as the time.
What that means practically: a pen left in a cool hallway overnight may be within limits; the same pen left on a sun-facing windowsill or in a warm car for a few hours may not be, even if the total time is shorter. Semaglutide is a protein-based molecule, and heat degrades it in ways that are invisible, the liquid looks identical whether the medicine is intact or partially degraded. That invisibility is exactly why the manufacturer sets hard limits rather than asking you to judge by eye.
Once you have checked the SmPC and leaflet, if you are still unsure, call your pharmacist or prescriber. That is the right call, every time. You can also find broader storage and travel context on taking Wegovy out of the fridge and on the dedicated page covering how long Wegovy can be unrefrigerated.
Wegovy's active ingredient, semaglutide, is a GLP-1 receptor agonist manufactured as a biological medicine. Biological medicines are inherently more sensitive to temperature than small-molecule drugs like paracetamol. The fridge requirement is not a formality or a conservative estimate; it reflects the physical chemistry of how proteins behave when warm.
Above the permitted room-temperature ceiling, semaglutide molecules begin to denature, their structure changes in ways that reduce biological activity. The degradation is not linear: higher temperatures accelerate it significantly, so a pen left at 30°C degrades meaningfully faster than one sitting at 22°C, and both degrade faster than one sitting at 18°C. The SmPC temperature limit accounts for this, setting a ceiling that preserves efficacy within the specified time window.
There is also the question of light. The pens should be kept away from direct sunlight at all times, whether refrigerated or not. UV exposure is a separate degradation pathway from heat, which is why the pen cap and outer carton both provide protection, keep the pen capped and in its box until you are ready to use it.
Freezing is a different kind of problem entirely. A frozen pen is not merely degraded; it may also contain ice crystals that affect the delivery mechanism. The SmPC is unambiguous: if a pen has been frozen, discard it. Do not let it thaw and attempt to use it. For practical questions about whether a pen that spent time near the freezer compartment counts, consult your pharmacist directly, the guide for patients who have left a Wegovy pen out covers common edge cases in more detail.
Once you have started a pen and used it for your first weekly dose, the same storage rules apply to the remaining doses in that pen, which for most Wegovy formats means three further injections are to come. You do not get a fresh room-temperature allowance each week; the clock for unrefrigerated storage is cumulative from the first time the pen came out of the fridge for a meaningful period.
Travel is where this gets most complicated. A long-haul flight, a weekend away, or even a hot commute can push a pen close to or past the permitted limit if it is not kept in an insulated cool bag. The NHS England page on weight-management injections advises patients to plan ahead and keep medicines stored correctly, that means packing a small insulated case with an ice pack for journeys where you cannot guarantee temperatures, and keeping the pen away from the overhead locker in direct sun on planes.
When the room-temperature window closes and the pen has not been returned to the fridge, do not use it. Disposing of a pen is a loss, and if cost is a concern it is worth looking at how Wegovy is priced through different UK providers to understand what replacement actually costs. But using a degraded pen does not just mean a missed dose, it means injecting a medicine that may have lost potency or changed in other ways, and that is not worth the risk. Sharps disposal is straightforward with a proper sharps container, which keeps used and discarded pens safe until they can be collected.
One practical detail worth building into your routine: treat the injection like the first thing after the kettle goes on, pen out of the fridge, cap off, injected, cap on and back in the fridge within a few minutes. The less time it spends at room temperature by habit, the further you stay from any storage limit.
If you genuinely cannot tell whether your pen is still within the unrefrigerated window) perhaps you found it after a holiday and cannot recall exactly when it was last refrigerated, the answer is to contact your prescriber or pharmacist before using it. This is not overcaution; it is the right clinical step. A degraded pen does not look or feel different, and the consequences of reduced efficacy build up quietly over weeks.
At nume, every patient has access to priority aftercare seven days a week, so storage questions can be put to a real prescriber quickly. Our clinical team reviews these queries personally rather than routing them through an automated response. If you are not currently a patient and are weighing up private treatment, the Wegovy treatment overview covers how the process works from consultation through to delivery. For more on what responsible storage looks like across the treatment, the full Wegovy out-of-fridge guide is a good place to start.
Wegovy is a prescription-only medicine, and the clinical relationship does not end at the point of dispensing. Storage, side effects, dose changes, all of it falls within the scope of your prescriber. If you have questions about starting treatment, you can begin a free consultation and have your case reviewed the same day by a GPhC-registered prescriber.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.